UK Markets close in 3 hrs 27 mins

Inari Medical, Inc. (NARI)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
59.62-0.47 (-0.78%)
At close: 04:00PM EDT
59.62 0.00 (0.00%)
After hours: 04:17PM EDT
Sign in to post a message.
  • A
    Anonymous
    I'm wondering if the "fantastic position we're going to be in post-COVID" is leaking...
    $199!
  • D
    Dan
    it's goin down because the big boys want to get in
  • Y
    Yahoo Finance Insights
    Inari Medical is up 9.22% to 83.00
  • Y
    Yahoo Finance Insights
    Inari Medical is down 9.65% to 56.53
  • Y
    Yahoo Finance Insights
    Inari Medical is down 9.16% to 64.78
  • Y
    Yahoo Finance Insights
    Inari Medical reached a 52 Week low at 62.69
  • Y
    Yahoo Finance Insights
    Inari Medical is down 8.53% to 76.27
  • D
    Dragan
    There is 50 M outstanding shares, so 2 M is not much of dilution.
    They are profitable, they have 179 M cash and only 29 M debt.
    Why this offering, they do not need money? It could be some acquisition.
    Any second offering with intention to grow business is a wise decision.
  • Y
    Yahoo Finance Insights
    Inari Medical reached a 52 Week low at 60.64
  • Y
    Yahoo Finance Insights
    Inari Medical is up 8.13% to 94.00
  • K
    K B B
    now I know why Penumbra is the better stock ... this is going down to $50 with the dilution. No wonder there was something fishy with the runup to the high 90s.
  • G
    Glen
    Investing right now will be at every wise individual list. In few weeks you'll be ecstatic with the decision you made today
  • A
    Anonymous
    amazing, blew it out of the water.

    - revenue 144% over last year
    - 2x forecast for this year
    - earnings crossed over to positive
    - huge margins
    + entering new European market
    + 2 new products

    I think we'll see $199 before the end of the year
  • M
    Moe
    wasn't expecting it to open at double the price but that's fine. this company sells 2 very successful products and they have HUGE demands for them. worth the 45 a stock buy in. it will be over 300 in 5 years.
  • A
    Anonymous
    what i got out of the call:
    procedure is super safe, super effective above anything else.
    replenishment product pipeline seems stable and established, increased due to new product introductions.
    european foothold established, especially in western europe.
    a pipeline of tangential new products can be expected to be released Q4 through the 1H of next year, in addition to flowsaver.
    TAM related to Covid induced clots was 11% in Q2 and decreasing from Q1, down to 4% recently, yet total TAM increased...
    which means (unfortunately) the significant Q3 spike we're seeing in Covid now is going to be on top of the increase in "normal"/target (non-Covid) procedures.
  • s
    stocktracker000
    Wow!

    This company must have multi-billion dollar product. MC=1.7 billion...

    Talk about potential for growth...

    Good Luck and do your due diligence always...
  • A
    Anonymous
    any news to account for a 12% drop?
  • K
    K B B
    You bet the high valuation is justified !!!

    113% yoy revenue growth ... beats both top and bottom line ... 13c vs 5c and 57.4M vs 55M revs ... cash increased from $164M to $174M.

    Full year guidance increased from 234M to 245M.
  • A
    Abulurd
    So, the company hit their target and has great prospects, of course the stock tanks? Do I not understand what this whole thing is about anymore?